A clinically acceptable modified erythrocyte concentrate with long shelf-life can now be readily provided even after complete removal of all available plasma for fractionation. The concentrates have been evaluated in an uneventful clinical trial.
|Number of pages||3|
|Journal||Medical Journal of Australia|
|Publication status||Published - 1981|